Steve Mertens
2023
In 2023, Steve Mertens earned a total compensation of $457.7K as Chief Technology Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $66,453 |
|---|---|
| Option Awards | $45,951 |
| Salary | $265,810 |
| Stock Awards | $79,500 |
| Total | $457,714 |
Mertens received $265.8K in salary, accounting for 58% of the total pay in 2023.
Mertens also received $66.5K in non-equity incentive plan, $46K in option awards and $79.5K in stock awards.
Rankings
In 2023, Steve Mertens' compensation ranked 1,707th out of 2,209 executives tracked by ExecPay. In other words, Mertens earned more than 22.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,707 out of 2,209 | 23rd |
Division Manufacturing | 959 out of 1,195 | 20th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 133 out of 185 | 28th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 81 out of 122 | 34th |
Industry Surgical and Medical Instruments and Apparatus | 72 out of 102 | 29th |
Source: SEC filing on January 29, 2024.
Mertens' colleagues
We found two more compensation records of executives who worked with Steve Mertens at NEUROONE MEDICAL TECHNOLOGIES Corp in 2023.
News
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2023 pay slips 17% to $990K
January 29, 2024
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2022 pay falls 37% to $1.2M
January 27, 2023
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2021 pay jumps 67% to $1.9M
April 29, 2022
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2020 pay jumps 103% to $1.1M
May 6, 2021